Sangui Biotech International, Inc.
Sangui Biotech International, Inc., often referred to as Sangui Biotech, is a pioneering company headquartered in Delaware, USA. Founded in 2001, the firm operates primarily in the biotechnology sector, focusing on innovative solutions for medical and therapeutic applications. With a commitment to advancing healthcare, Sangui Biotech has developed a range of unique products, including cutting-edge blood substitutes and advanced wound care technologies. The company has achieved significant milestones, positioning itself as a leader in the field of biopharmaceuticals. Its core offerings are distinguished by their ability to enhance patient outcomes and improve quality of life. With a strong presence in both domestic and international markets, Sangui Biotech continues to drive innovation and maintain a competitive edge in the rapidly evolving biotechnology landscape.
DitchCarbon Score
How does Sangui Biotech International, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sangui Biotech International, Inc.'s score of 20 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sangui Biotech International, Inc.'s reported carbon emissions
Sangui Biotech International, Inc., headquartered in Delaware, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Sangui Biotech International, Inc. aligns with industry standards for climate action. The absence of specific targets or commitments may reflect a broader trend within the biotech sector, where companies are increasingly being called upon to disclose their environmental impact and set measurable goals for emissions reduction. In summary, without available emissions data or climate commitments, Sangui Biotech International, Inc. currently lacks transparency regarding its carbon footprint and climate strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sangui Biotech International, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
